TheWealthWeb

Baroda BNP Paribas Health and Wellness Fund Direct Growth

Baroda BNP Paribas Mutual FundEquity Scheme - Sectoral/ ThematicDirect · GrowthRisk: Very high

NAV ₹11.3132 on 13 November 2026

1 year
+16.61%
Since launch, a year
+9.33%
NAV performance, last year

Returns

To 13 November 2026. Up to 1 year: total change. 3 and 5 years: compound return a year.

PeriodThis fundNIFTY 500 TRICategory median
1M+8.80%+7.53%+5.71%
6M+11.86%+6.80%+7.79%
1Y+16.61%+0.54%+4.11%
3Y-+12.13%+14.35%
5Y-+9.87%+12.25%

Benchmark: NIFTY 500 TRI (total return index), measured over the same dates. The scheme document names BSE Healthcare Total Return Index, which we do not hold, so this is the closest NSE index.

Category median: the middle return among Direct plans (Growth option) in AMFI's “Equity Scheme - Sectoral/ Thematic” category, up to 174 funds with clean data. Ranks are under “Rank among peers”.

Risk

From daily NAVs. Alpha, beta and capture are measured against NIFTY 500 TRI.

Volatility
12.72%
Annualised, 1 year
Max drawdown
-11.11%
Worst fall from a peak, 3 years
Sharpe ratio
0.83
Return above the risk-free rate per unit of volatility, 1 year
Sortino ratio
0.48
Like Sharpe, counting only falls, 3 years
Alpha
+5.97%
Return a year beyond what beta explains, 3 years
Beta
0.57
1.00 moves in step with the benchmark, 3 years
Upside capture
49%
Share of the benchmark's rises captured, 3 years
Downside capture
64%
Share of the benchmark's falls taken (lower is better), 3 years

Rank among peers

Direct plans, Growth option, in AMFI's “Equity Scheme - Sectoral/ Thematic” category. Each rank counts only the peers that have that figure.

Compare with Top Peers
3-Year Return Rank
-of 142
-
N/A
Q1
Q2
Q3
Q4
1-Year Return RankQ1
#38of 233
+16.61%
Ahead of 195 of the other 232
Q1
Q2
Q3
Q4
Sharpe (Risk-Adjusted)Q1
#37of 233
0.83
Ahead of 196 of the other 232
Q1
Q2
Q3
Q4
Highest 3-year returns in the categoryDirect plans · Growth option
RankScheme Name3Y Return1Y ReturnSharpeDirect TERAUM
#1
Nippon India Mutual Fund
+46.52%+60.64%1.071.06%₹1,100 Cr
#2
HDFC Mutual Fund
+33.64%+20.34%1.070.89%₹11,128 Cr
#3
HDFC Mutual Fund
+31.28%+31.60%1.761.03%₹3,128 Cr
#4
SBI Mutual Fund
+25.42%+26.07%1.470.76%₹5,565 Cr
#5
HDFC Mutual Fund
+24.77%+10.10%1.091.10%₹1,997 Cr
#6
Mirae Asset Mutual Fund
+24.42%+27.89%1.28-₹3,458 Cr
#7
UTI Mutual Fund
+23.89%+22.00%1.311.35%₹1,399 Cr
#8
ICICI Prudential Mutual Fund
+22.73%+10.29%0.952.08%₹3,926 Cr
#-
Baroda BNP Paribas Health and Wellness FundCurrent Fund
Baroda BNP Paribas Mutual Fund
-+16.61%0.831.47%₹511 Cr

Costs and fund facts

Expense ratio (stated maximum)
Direct 1.47% · Regular 2.70%
Exit load
Redemption/ switch out of units upto 10% of the units allotted before 1 year from date of allotment- Exit load -NIL For redemption/switch out of units above 10% of units allotted within 1 year from the date of allotment- 1.00% of applicable NAV For redemption/switch out of units after 1 year from the date of allotment-Nil
Fund size (all plans)
₹511 CrAverage, quarter to September 2026
Benchmark
BSE Healthcare Total Return IndexCompared here with NIFTY 500 TRI
Allotment date
27 June 2025Scheme document
Type
An open ended equity scheme investing in Pharma and Healthcare sector
AMFI scheme code
153604

Fund managers (2)

  • Rohan Korde
  • Ankeet Pandya

How each manager has done since taking over: fund manager scorecard.

Investment objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.

From the scheme summary document filed with AMFI.

SIP calculator

A monthly SIP replayed on this fund's actual daily NAVs: what it would be worth today.

Monthly SIP Amount₹10,000
Investment Horizon5 Years
Simulating monthly 1st from 1 Jul 2025 to 13 Nov 2026
Total Invested17 mos
₹1,70,000
Units: 17,066.493
Current Portfolio Value
₹1,93,077
At latest recorded NAV
Total Profit
+₹23,077
+13.6% absolute return
SIP XIRR
19.52%
Annualised, money-weighted
Wealth CompositionProfit is 14% of total invested capital
Invested: ₹1,70,000Profit Generated: ₹23,077
Same SIP in the benchmark (NIFTY 500 TRI)Same dates & amounts
Scheme SIP Valuation
₹1,93,077
19.5% XIRR
Benchmark SIP Valuation
₹7,95,484
10.6% XIRR
Fund minus benchmark
₹-6,02,407
Over 17 monthly installments
SIP instalments are bought on the first NAV date of each month; values use the latest NAV we hold. Past returns are not a guide to future returns.

About this fund

Baroda BNP Paribas Health and Wellness Fund Direct Growth is a mutual fund scheme from Baroda BNP Paribas Mutual Fund, listed by AMFI under “Equity Scheme - Sectoral/ Thematic”. This page covers the Direct plan with the Growth option. Its NAV was ₹11.3132 on 13 November 2026. It returned 16.61% over 1 year, measured from NAVs (3- and 5-year figures are annualised). Its benchmark, NIFTY 500 TRI, returned 0.54% over 1 year. Q-Score: 69 out of 100, rated only against funds in the same category. The fund house rates its risk as “Very high” on the SEBI riskometer. Its average assets under management were ₹511 Cr across all plans for the quarter ending September 2026, as reported to AMFI. Its scheme summary document states a maximum expense ratio (TER) of 1.47% a year for the Direct plan. Managed by Rohan Korde and Ankeet Pandya. Its scheme summary document gives the allotment date as 27 June 2025.

Figures are calculated from AMFI NAVs and index data, not taken from fund factsheets. Methodology. Past performance is not a guide to future returns.

Plans and options of this fund (4)

PlanOptionISINAMFI codeNAV
DirectThis pageGrowthINF251K01VA5153604₹11.3113 Nov 2026
DirectIDCWINF251K01VC1153605₹11.3113 Nov 2026
RegularGrowthINF251K01UY7153602₹11.0513 Nov 2026
RegularIDCWINF251K01UZ4153607₹11.0513 Nov 2026